ACCESSWIRE
22 Feb 2021, 19:25 GMT+10
Kagocel and Sputnik V gain confidence from the medical community
MOSCOW, RUSSIA / ACCESSWIRE / February 22, 2021 / Despite the launch of multiple COVID-19 vaccines, the rollout for production and administration of these vaccines has been extremely slow around the world. Israel has been the sole country to immunize more than half its population. Meanwhile, most European countries as well the United States have struggled. Their vaccination rate has not allowed them to turn the tide of morbidity - there are simply not enough vaccines for everyone and there are logistical hurdles with transportation and storage that need to be overcome. In the midst of these ongoing challenges, Kagocel and Sputnik V have emerged from Russia as promising contenders in the fight against coronavirus.
Sputnik was one of the world's first COVID-19 vaccines to be developed. The scientific magazine Lancet released an article on the Russian coronavirus vaccine, confirming its high efficacy rate of 91.6% for full protection against severe cases. The World Health Organization has also officially recognized the Lancet article as proof of Sputnik V's efficiency. Despite the establishment of its efficacy and credibility, registering this Russian medication in countries in the European Union has faced local opposition and hesitancy.
Despite the efficacy of Sputnik V and other vaccines, the emergence of new coronavirus strains is making it clear that there is no 100% guaranteed protection against all forms of COVID-19. The recently identified British strain has been found to be highly infectious. Moreover, according to British Sky News, scientists have also identified a second type of that new strain, which is likely to be able to interact with the vaccine in a special way and even counteract it. Another strain was also discovered in South Africa, adding to the growing concern around the world about the likelihood of success with any vaccine for all of these additional strains.
In addition to Sputnik V, there is a second medical solution in the fight against COVID-19 that has emerged from Russia. Kagocel is a very popular anti-viral drug that uses interferon inducers which increase the body's resistance to any viral infections. Interferon inducers have been used extensively for the past several years in Russia to prevent standard ARVI (commonly known as a cold) and influenza. Kagocel has been recommended by the Russian Ministry of Health for years. The World Health Organization has also recognized the promising potential of such medications. The development of immunomodulators is one of the tasks of the Global Influenza Strategy 2019-2030 as well as the BRaVe, the ARVI Initiative.
While vaccines like Sputnik V and drugs like Kagocel have been proven successful, there is still pushback from countries like the U.S. and those in the EU about using these Russian medical solutions. 'There are not many drugs using interferon inducers on the pharmaceuticals market. They were developed 45-50 years ago in the USSR,' explained Alexander Ginzburg, director of The Gamaleya Research Institute of Epidemiology and Microbiology in Russia. 'I'd not be revealing a big military secret if I say that they were developed to protect organized collectives, because the massive influx of people facilitates the spread of the infection. When perestroika began, these drugs were very quickly put into commercial use. In Western medicine, I do not know their analogues. It would be a significant missed opportunity to overlook interferon inducers in the fight against COVID-19'.
Media Contact
Company: Nearmedic
Contact: Yulia Felonina, Head of Public Relations department
Telephone: +7 (916) 581-37-32
E-mail: yuliya.felonina@nearmedic.ru
Website: https://nearmedic.ru
Address: 12 Aviakonstruktora Mikoyana St, Linkor Office Center, build.A, 2nd floor, Moscow,125167, Russia
SOURCE: Nearmedic
Get a daily dose of Miami Mirror news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Miami Mirror.
More InformationSYDNEY, NSW, Australia - Stocks in Asia mostly fell on Monday, although the Australian market managed a modest gain.The passage ...
BANGALORE, India: Contrary to analysts' predictions, OPEC and its allies decided to leave oil production unaffected until April, citing the ...
U.S. retail giant Target saw its revenues rise 21 percent year-on-year to $28.34 billion in the quarter ending in January, ...
AUSTIN, Texas: Aviation and aerospace company SpaceX is expanding its presence to align with global demand by setting up a ...
GOTHENBURG, Sweden: Volvo targets to only manufacture electric cars by 2030 by significantly increasing the size of its U.S. South ...
CUPERTINO, California: Apple announced on Monday that all 270 of its store locations in the U.S. have officially opened for ...
LONDON, England: In a bid to reduce Covid infections among overweight Britons, Prime Minister Boris Johnson is promoting his own ...
VANCOUVER, Canada: Lawyers for Huawei chief financial officer Meng Wanzhou have sought a dismissal of the extradition case against her, ...
REYKJAVIK, ICELAND - The volatile islands of Iceland have experienced unusual seismic activity in the past week, with over 18,000 ...
Yemen's Houthi rebels have carried out missile and drone strikes on a Saudi military base and an oil facility, expanding ...
BERLIN, Germany: In a change of policy, Germany has announced it will begin vaccinating those over 65 years-old, while recommending ...
WASHINGTON D.C.: Compromising with moderates, President Joe Biden and Democrats agreed to tighten the requirements for those eligible to receive ...